Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study

被引:0
|
作者
Gurley, Tami [1 ]
Hernaez, Ruben [2 ,3 ]
Cerda, Vanessa [1 ]
Thomas, Tynaje [1 ]
Narasimman, Manasa [4 ]
Mittal, Sukul [4 ]
Al-Hasan, Mohammed [4 ]
Daher, Darine [4 ]
Singal, Amit G. [4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Donnell Sch Publ Hlth, Dallas, TX USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Houston, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
关键词
Liver cancer; Screening; Ultrasound; Outreach; Interventions; HEPATOCELLULAR-CARCINOMA SURVEILLANCE; DECOMPENSATED CIRRHOSIS; ASSOCIATION; OUTCOMES; QUALITY; DISEASE; LIFE;
D O I
10.1016/j.eclinm.2025.103113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC), but few undergo guideline- recommended semi-annual screening. Randomized clinical trials (RCTs) demonstrate that mailed outreach can increase screening versus visit-based screening. We estimated the costs and cost-effectiveness of an outreach strategy versus usual care. Methods We built a 10-year Markov chain Monte Carlo microsimulation model to conduct a cost-effectiveness analysis comparing a mailed outreach program versus usual care for HCC screening in a cohort of 10,000 patients with cirrhosis. Model inputs were based on literature review (2005-current), and costs were based on inflation-adjusted estimates from Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data. We conducted one-way sensitivity analyses for HCC incidence, outreach costs, efficacy of the outreach strategy to increase screening, and efficacy of curative (versus palliative) HCC treatments. Findings Mailed outreach was estimated to cost $32.45 per patient in the first year and $21.90 per patient in subsequent years. The outreach program increased the number of HCC patients detected at an early stage by 48.4% and increased quality-adjusted life years (QALYs) by 300. Cost savings from these increases offset the costs of mailed outreach. Mailed outreach remained cost-effective across a wide range of HCC incidence rates, outreach costs, efficacy of the outreach strategy to increase screening, and the efficacy of curative HCC treatments. Annual out-ofpocket patient costs in the outreach arm were low at $13 per year. Interpretation Mailed outreach to encourage HCC screening in patients with cirrhosis dominates usual care and should be considered for implementation in routine practice. Funding National Cancer Institute and Cancer Prevention Research Institute of Texas. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study
    Du, Yihui
    Sidorenkov, Grigory
    Heuvelmans, Marjolein A.
    Groen, Harry J. M.
    Vermeulen, Karin M.
    Greuter, Marcel J. W.
    de Bock, Geertruida H.
    EUROPEAN JOURNAL OF CANCER, 2020, 135 : 121 - 129
  • [42] Treatment of ascites in patients with cirrhosis: A cost-effectiveness analysis.
    Gines, P
    Uriz, J
    Trilla, A
    Blei, A
    Cardenas, A
    Ortega, R
    Calahorra, B
    Arroyo, V
    Asenjo, M
    Rodes, J
    HEPATOLOGY, 2001, 34 (04) : 549A - 549A
  • [43] COST-EFFECTIVENESS OF ULTRASOUND VS MRI FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN CIRRHOSIS: A COMPARATIVE MODELING STUDY
    Anya, Eugenia Uche
    Wilechansky, Robert M.
    Balogun, Oluwafemi
    Simon, Tracey
    Chhatwal, Jagpreet
    Corey, Kathleen E.
    GASTROENTEROLOGY, 2023, 164 (06) : S1409 - S1410
  • [44] Modeling the cost-effectiveness of a community based health promotion program
    Ramsey, SD
    Patrick, DL
    Spencer, AC
    MEDICAL DECISION MAKING, 1998, 18 (04) : 459 - 459
  • [45] Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma
    Singal, Amit G.
    Tiro, Jasmin A.
    Marrero, Jorge A.
    McCallister, Katharine
    Mejias, Caroline
    Adamson, Brian
    Bishop, Wendy Pechero
    Santini, Noel O.
    Halm, Ethan A.
    GASTROENTEROLOGY, 2017, 152 (03) : 608 - +
  • [46] Use of modeling to evaluate the cost-effectiveness of cancer screening programs
    Knudsen, Amy B.
    McMahon, Pamela M.
    Gazelle, G. Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) : 203 - 208
  • [47] Simulation modeling of lung cancer screening cost-effectiveness analysis
    Wan, W.
    ANNALS OF ONCOLOGY, 2015, 26 : 156 - 156
  • [48] Cost-effectiveness of new screening strategies for hepatocellular carcinoma (HCC)compared to ultrasound(US)
    Russo, Mark W.
    Sterling, Richard K.
    HEPATOLOGY, 2007, 46 (04) : 411A - 411A
  • [49] Cost-effectiveness of a diabetes education program for Medicaid patients
    Ohsfeldt, RL
    Phillips, M
    Balamurugan, A
    Hughes, TE
    DIABETES, 2005, 54 : A307 - A307
  • [50] Performance of screening strategies for primary prophylaxis of variceal bleeding in patients with compensated cirrhosis: a cost-effectiveness analysis
    Lin, Shanshan
    Liu, Chuan
    He, Zonglin
    Gu, Ye
    Wang, Yan
    Yang, Qing
    Shao, Jianbo
    Ge, Guohong
    Zhou, Shengqiang
    Zhang, Guo
    Wang, Wenjuan
    Wang, Xing
    Wu, Bin
    Ming, Wai-Kit
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2021, 75 : S650 - S651